title: Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer.
authors.affiliation: Division of Surgical Oncology, Department of Surgery, Duke University Medical Center, Durham, NC, USA.
authors.forename: Hamza
authors.initials: H
authors.lastname: Aziz
authors.forename: P Kelly
authors.initials: PK
authors.lastname: Marcom
authors.forename: E Shelley
authors.initials: ES
authors.lastname: Hwang
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases